CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...
The device is established in Europe, where the company said it has a 60% market share, but will be the first product of its type available in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback